Demand and supply.
Most brokers respond to clients' requests for coverage - especially institutional clients.
Be grateful that brokers come lately so their clients buy the shares at higher prices!
Printable View
More media coverage...
https://www.stuff.co.nz/business/far...d-american-vet
Few snippets from above article...
"People think de-horning is absolutely brutal. Go for polled animals.
"New Zealand listen to me, if in 10 years you can sell milk to the world that came from polled animals that were A2/A2 you would wipe out the competition."
Wow, take at look at the BAL share price on the ASX, waiting patiently for the next A2 run. PS-BAL has outperformed A2 over the last year.
If you want to have a bit of fun while you wait, bring up a chart for the last 12 months of ATM, click on super charts and compare how closely ATM's SP correlates to BAL's SP over the last 12 months.
How closely will really surprise you, its really really closely correlated.
The shorten the chart period up to 3 months and you'll see than notwithstanding the Fonterra about face on A2 and the wonderful implications that gives for long term supply and growth for ATM the BAL SP has materially outperformed in the last 3 months.
Expecting a market update sometime late April, (as they did last year), and the next leg up as a result of that.
May 14 should see index inclusion in the MSCI world index with the addition and rebalance effective on 1 June.
Later in June 2018 just like last year I expect another market update. Plenty to look forward too over the next few months :t_up:
Been reading about platypus milk in the herald, as a possible source of new antibiotics..... and I was thinking about the A2 Platinum brand .... and nah, don’t think we should go there ...... nahhhh!!
210,000 at $13.525 crossed after market closed.
Edit. But opened next day at $13.75. Now lets see what ripple SML announcement causes.
Anyone else notice that nice little snippet in the SML half year results that said all consents for the Pokeno plant have been received....or words to that effect.
Underwrites their ability to supply A2 infant formula going forward into 2019 and beyond. Good for SML AND ATM shareholders, a classic win-win
Beagle have this funny thing about ducks. When they all start to line up beautifully its a sure sign that happy times will be continuing :t_up:
Interesting article behind the paywall on NBR today wherein head of Equities at Nikko Fund managers Stuart Williams opines on FBU and ATM
Summary. FBU needs asset sales and / or equity raise to get through their mess.
Shares are seen as expensive at 16.5 times forward earnings because earnings are probably wrong.
At the other end of the attractiveness scale they reckon, (and they've been shareholders since 2012) that ATM is cheap on 38 times FY18 earnings given their proven growth rate and clear pathway to substantial further growth over the next 3-5 years.
Good to know what the institutions are thinking as there's serious money behind their opinions.